51-49-0 | D-Thyroxine

Packsize	Purity	Availability	Price	Discounted Price
1mg	97	in stock	$110.00	$77.00
100mg	97%	in stock	$139.00	$97.00
250mg	97%	in stock	$251.00	$176.00
1g	97%	in stock	$605.00	$423.00

Description

• Catalog Number: AD20914
• Chemical Name: D-Thyroxine
• CAS Number: 51-49-0
• Molecular Formula: C15H11I4NO4
• Molecular Weight: 776.8700
• MDL Number: MFCD00063056
• SMILES: OC(=O)[C@@H](Cc1cc(I)c(c(c1)I)Oc1cc(I)c(c(c1)I)O)N

Computed Properties

• Complexity: 420
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 5
• XLogP3: 2.4

Literature

• LDL-apheresis: technical and clinical aspects.

  TheScientificWorldJournal 20120101

• Familial hypercholesterolemia: present and future management.

  Current cardiology reports 20111201

• Thyroid hormone and cardiac disease: from basic concepts to clinical application.

  Journal of thyroid research 20110101

• Layer-by-layer assembled molecularly imprinted polymer modified silver electrode for enantioselective detection of D- and L-thyroxine.

  Analytica chimica acta 20101129

• Enatioselective quantitative separation of D- and L-thyroxine by molecularly imprinted micro-solid phase extraction silver fiber coupled with complementary molecularly imprinted polymer-sensor.

  Journal of chromatography. A 20100625

• Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

  Drug, healthcare and patient safety 20100101

• 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).

  Journal of pediatric endocrinology & metabolism : JPEM 20091001

• In-line coupling of a reversed-phase column to cope with limited chemoselectivity of a quinine carbamate-based anion-exchange type chiral stationary phase.

  Journal of separation science 20080601

• [Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones].

  Medicina clinica 20080315

• Resistance to thyroid hormone with missense mutation (V349M) in the thyroid hormone receptor beta gene.

  The Korean journal of internal medicine 20080301

• A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.

  Thyroid : official journal of the American Thyroid Association 20080101

• Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.

  Journal of medicinal chemistry 20071115

• Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat.

  Life sciences 20060905

• The elemental importance of sufficient iodine intake: a trace is not enough.

  Endocrinology 20060501

• Short-term stimulation of lipogenesis by 3,5-L-diiodothyronine in cultured rat hepatocytes.

  Endocrinology 20050901

• Simultaneous determination of l-thyroxine (l-T(4)), d-thyroxine (d-T(4)), and l-triiodothyronine (l-T(3)) using a sensors/sequential injection analysis system.

  Talanta 20040908

• Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.

  Endocrinology 20040901

• Inhibition of the activity of the native gamma-aminobutyric acid A receptor by metabolites of thyroid hormones: correlations with molecular modeling studies.

  Brain research 20040409

• Thyroid Hormone Resistance in children.

  Pediatric endocrinology reviews : PER 20031201

• Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.

  The Journal of biological chemistry 20031010

• Nuclear receptor agonists stimulate release of arachidonic acid from rat liver cells.

  Prostaglandins, leukotrienes, and essential fatty acids 20021201

• Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.

  Molecular pharmacology 20020401

• Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.

  Arteriosclerosis (Dallas, Tex.) 19890101

• Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults.

  The Journal of clinical endocrinology and metabolism 19801201

• Dextrothyroxine for lowering cholesterol.

  The Medical letter on drugs and therapeutics 19760618

• Evaluation of a hypocholesterolemic agent. Dextrothyroxine sodium (Choloxin).

  JAMA 19690512